Scand J Trauma Resus
-
Scand J Trauma Resus · Oct 2023
Editorial Randomized Controlled TrialThe end of balloons? Our take on the UK-REBOA trial.
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is increasingly used. The recently published UK-REBOA trial aimed to investigate patients suffering haemorrhagic shock and randomized to standard care alone or REBOA as adjunct to standard care and concludes that REBOA may increase the mortality. ⋯ The situation is complex, and the patients are in extremis. In summary, we do not think this is the end of balloons.
-
Scand J Trauma Resus · Feb 2019
Editorial CommentPermissive hypotensive resuscitation in patients with traumatic hemorrhagic shock.
We read the article "Risks and benefits of hypotensive resuscitation in patients with traumatic hemorrhagic shock: a meta-analysis" by Natthida Owattanapanich et al. with great interest and found it to be insightful. In our commentary, we propose possible reasons why mortality was lower in the permissive hypotension group and how the need for blood transfusion decreased in this group. No significant difference in acute kidney injury (AKI) was evident among patient groups, possibly because all these patients might have AKI. However, we do agree that permissive hypotension is of considerable benefit to trauma patients and worth further study.